CSPC PHARMACEUTICAL GROUP LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 1093/N for the last semiannual is 41.44 B MXN, and it's 14.76% higher compared to the previous semiannual. The net income of H1 24 is 7.69 B MXN.